Pearson Stock News

Educational provider Pearson reported underwhelming annual results.

Here is how Boyd Gaming (BYD) and Pearson (PSO) have performed compared to their sector so far this year.

PSO vs. RSVR: Which Stock Is the Better Value Option?

Pearson PLC (LSE:PSON) (Pearson PLC (LSE:PSON)) has rejected a third takeover offer from US investment group Apollo worth 884p per share leading the US private equity firm to admit defeat and walk awa

NEW YORK , March 15, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HYMC, EXN, AVGR, PSO, and RKDA. … Full story available on Benzinga.com

The redevelopment will feature 13,000 sq metres of exhibition space, a rooftop terrace and restaurant Get our free news app ; get our morning email briefing The final design of the National Gallery of Victoria’s contemporary arts space has been unveiled, with the state’s creative industries minister, Danny Pearson, describing it as Melbourne’s equivalent to the Eiffel Tower. Pearson on Tuesday announced the winning design, by Angelo Candalepas and Associates, which includes 13,000 sq metres of exhibition space, a rooftop terrace and restaurant with CBD views, a 40-metre-high spherical entrance hall and scientific laboratories for the conservation of art. Continue reading…

Gainers Marygold Companies (NYSE: MGLD ) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday. TeraWulf Inc. (NASDAQ: WULF ) gained 49.3% to close at $9.51. Guardforce AI Co., Limited (NASDAQ: GFAI ) jumped 45% to settle at $0.7796 after the company agreed to acquire Shenzhen Keweien and Guangzhou Kewei for $10 million. Clearside Biomedical, Inc. (NASDAQ: CLSD ) rose 42.6% to settle at $1.9250 after the company reported better-than-expected Q4 results. Excellon Resources Inc. (NYSE: EXN ) rose 40.8% to close at $1.38 after jumping around 13% on Thursday. Solid Biosciences Inc. (NASDAQ: SLDB ) jumped 37.4% to settle at $1.06. Altamira Therapeutics Ltd. (NASDAQ: CYTO ) shares gained 36.7% to settle at $0.9449. Altamira Therapeutics reported in vitro efficacy data for bentrio nasal spray in protecting against Sars-CoV-2 omicron variant. 4D pharma plc (NASDAQ: LBPS ) shares surged 35.3% to settle at $3.99. Kala Pharmaceuticals, Inc. (NASDAQ: KALA ) gained 33.1% to close at $1.69.

We will focus on anything that increases the education which is relevant, or skills that are relevant to the 21st century, says Siddharth Banerjee, MD India & Asia, Pearson

Stocks that traded heavily or had substantial price changes Friday: DocuSign, Zumiez fall; Pfizer, Pearson rise

Gainers Marygold Companies (NYSE: MGLD ) jumped 189.4% to $6.28 after dropping 21% on Thursday. Altamira Therapeutics Ltd. (NASDAQ: CYTO ) shares rose 63.5% to $1.13. Altamira Therapeutics reported in vitro efficacy data for bentrio nasal spray in protecting against Sars-CoV-2 omicron variant. Excellon Resources Inc. (NYSE: EXN ) rose 40.7% to $1.38 after jumping around 13% on Thursday. Clearside Biomedical, Inc. (NASDAQ: CLSD ) rose 35.5% to $1.8301 after the company reported better-than-expected Q4 results. Alset EHome International Inc. (NASDAQ: AEI ) shares rose 31% to $ 0.4555 after dropping 7% on Thursday. Humanigen, Inc. (NASDAQ: HGEN ) jumped 22.7% to $3.44. Lazydays Holdings, Inc. (NASDAQ: LAZY ) gained 22% to $21.80 after the company reported Q4 earnings results. Blue Star Foods Corp. (NASDAQ: BSFC ) jumped 19.8% to $2.54. 4D pharma plc (NASDAQ: LBPS ) shares climbed 19.7% to $3.53. Paramount Gold Nevada Corp. (NYSE: PZG ) rose 19% to $0.9404 after jumping 14% on Thursday. Pearson plc (NYSE: PSO ) gained 19% to $10.35.

U.K. education publishing group Pearson PLC (NYSE: PSO ) refused Apollo Global Management Inc''s (NYSE: APO ) March 7 takeover proposal for 854.2 pence per share which valued Pearson at £6.5 billion, Bloomberg reports . Previously, Pearson rejected Apollo''s November cash offer of 800 … Full story available on Benzinga.com

The company received an offer, rejected it, and then got a higher one. It looks like this publisher is in play.

UK education publisher Pearson has rejected a $8.5 billion takeover offer from Apollo, reported Reuters.

Pearson said on Friday it had rejected two takeover approaches from investment firm Apollo , saying its latest $8.5 billion possible cash offer undervalued the global education group, which was confident in its own strategy.